
Vriglim 1 Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Glimepiride (1gm)
Overview Vriglim 1 Tablet
Glimepiride, a sulfonylurea-class medication, is prescribed for adult patients with type 2 diabetes. This medicine helps regulate blood glucose, mitigating the risk of serious diabetic complications like vision impairment and kidney disease. Glimepiride may be administered alone or in conjunction with other therapies. Optimal efficacy is achieved by taking it immediately before or with the initial meal of the day, consistently at the same time. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use of glimepiride is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to dangerously elevated glucose levels, potentially causing kidney damage, blindness, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, also requiring a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), nausea, headaches, fatigue, and lightheadedness. Learn to identify hypoglycemia symptoms—sweating, dizziness, headaches, and tremors—and know how to manage them. Regular meals and readily available fast-acting glucose sources, such as sugary snacks or fruit juice, are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Weight gain may occur. Glimepiride is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any pre-existing heart, thyroid, or hormonal disorders before commencing treatment, as it may be unsuitable. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Vriglim 1 Tablet
No text was provided. Please provide the text you would like me to rephrase.
Uses of Vriglim 1 Tablet
Managing type 2 diabetes
Major Benefits of Vriglim 1 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Vriglim tablet with a meal.
Common Side effects of Vriglim 1 Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Vriglim 1 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vriglim 1 Tablet with a meal.
How Vriglim 1 Tablet works:
One Vriglim tablet is an antidiabetic agent that enhances pancreatic insulin secretion, thereby reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Vriglim 1 Tablet.
PregnancyCONSULT YOUR DOCTOR
Using Vriglim 1 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Vriglim 1 Tablet while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of the nursing infant's blood sugar levels is recommended when the mother takes Vriglim 1 Tablet.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Vriglim 1 Tablet cautiously, potentially requiring dosage modification under medical supervision. Vriglim 1 Tablet is contraindicated in patients with severe kidney disease due to the risk of significantly low blood glucose, a condition which may eventually resolve.
LiverCAUTION
Patients with liver impairment should use Vriglim 1 Tablet cautiously, potentially requiring dose modification under medical supervision. Vriglim 1 Tablet is contraindicated in those with severe hepatic disease due to the risk of significant hypoglycemia, which may resolve only after a prolonged period.
What if you forget to take Vriglim 1 Tablet :
Omit the forgotten Vriglim 1 Tablet dose and resume your regular medication schedule with the next scheduled intake.
Facts to Know About Vriglim 1 Tablet
| Label | Value |
|---|---|
| Chemical Category | Third-Generation Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
